Published in Psychopharmacology (Berl) on March 03, 2009
The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. PLoS One (2011) 1.07
Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study. Psychopharmacology (Berl) (2010) 1.07
Effects of Sumsu (Bufonis venenum) Pharmacopuncture Treatment on Depression in Mice. J Pharmacopuncture (2014) 0.88
Emerging and investigational drugs for premature ejaculation. Transl Androl Urol (2016) 0.75
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Neurobiology of depression. Neuron (2002) 8.56
The molecular neurobiology of depression. Nature (2008) 6.51
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) (2001) 5.67
Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry (2001) 5.11
Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry (1990) 4.08
Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev (1992) 4.06
Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci (2006) 3.96
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev (2005) 3.32
Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07
Association of different adverse life events with distinct patterns of depressive symptoms. Am J Psychiatry (2007) 2.90
Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology (2007) 2.88
Association of depression with medical illness: does cortisol play a role? Biol Psychiatry (2004) 2.05
Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther (2006) 2.04
Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry (2007) 2.01
Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep (2004) 2.01
Attention and executive functions in remitted major depression patients. J Affect Disord (2005) 1.84
Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry (2006) 1.77
Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry (1996) 1.73
Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology (2006) 1.72
The acoustic startle reflex: neurons and connections. Brain Res Brain Res Rev (1995) 1.70
Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci (1995) 1.63
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci (2004) 1.61
Selective activation of mesocortical DA system by stress. Nature (1976) 1.56
Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci (2001) 1.51
Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology (2007) 1.48
Effect of noxious tail pinch on the discharge rate of mesocortical and mesolimbic dopamine neurons: selective activation of the mesocortical system. Brain Res (1989) 1.45
Social discrimination procedure: an alternative method to investigate juvenile recognition abilities in rats. Physiol Behav (1995) 1.43
Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling. Proc Natl Acad Sci U S A (2007) 1.43
Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) (2007) 1.42
Sex differences in behavioral and neurochemical profiles after chronic stress: role of housing conditions. Physiol Behav (2002) 1.35
Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol (2008) 1.33
Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J Pharmacol Exp Ther (1997) 1.30
Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci U S A (2004) 1.30
Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry (2007) 1.28
Approved and investigational uses of modafinil : an evidence-based review. Drugs (2008) 1.28
Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol (1979) 1.26
Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur J Neurosci (2008) 1.26
Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. J Affect Disord (2006) 1.24
The role and mechanisms of action of glucocorticoid involvement in memory storage. Neural Plast (1999) 1.19
Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Mol Psychiatry (2004) 1.16
Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. Neuroreport (2001) 1.11
Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology (2001) 1.08
A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol (2004) 1.08
Effects of modafinil on working memory processes in humans. Psychopharmacology (Berl) (2004) 1.05
Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav (2005) 1.04
Prevalence and outcome of partial remission in depression. J Psychiatry Neurosci (2002) 1.01
Modafinil-induced modulation of working memory and plasma corticosterone in chronically-stressed mice. Pharmacol Biochem Behav (2006) 1.00
Measurement of startle response, prepulse inhibition, and habituation. Curr Protoc Neurosci (2001) 1.00
Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat. J Psychopharmacol (2005) 0.98
Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment. Psychopharmacology (Berl) (2007) 0.97
Attentional performance in patients with psychotic and nonpsychotic major depression and schizophrenia. Am J Psychiatry (1998) 0.97
Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment. Behav Pharmacol (1997) 0.96
Effects of antidepressants in the rat forced swimming test. Eur J Pharmacol (1981) 0.94
Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. J Psychiatr Res (2004) 0.92
Modafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats. Pharmacol Biochem Behav (2007) 0.92
Nonamphetamine awakening agent modafinil induces feeding changes in the rat. Brain Res Bull (1993) 0.92
Relationship of prepulse inhibition of the startle reflex to attentional and executive mechanisms in man. Int J Psychophysiol (2005) 0.91
Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats. Exp Neurol (2005) 0.90
Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat. Neurosci Lett (1995) 0.89
Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite (2004) 0.89
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry (2007) 0.89
Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study. J Clin Psychopharmacol (2007) 0.88
Prepulse inhibition of acoustic startle response in mild cognitive impairment and mild dementia of Alzheimer type. Psychiatry Clin Neurosci (2006) 0.88
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berl) (2005) 0.88
Attentional modulation of prepulse inhibition: a new startle paradigm. Neuropsychobiology (2004) 0.88
Stress modulation of the memory retrograde-enhancing effects of the awakening drug modafinil in mice. Psychopharmacology (Berl) (2007) 0.87
Modafinil decreases food intake in humans subjected to simulated shift work. Pharmacol Biochem Behav (2008) 0.86
Behavioural changes after different stress paradigms: prepulse inhibition increased after physical, but not emotional stress. Eur Neuropsychopharmacol (2003) 0.86
Prepulse inhibition in patients with non-psychotic major depressive disorder. J Affect Disord (2004) 0.84
Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Ann Pharmacother (2007) 0.81
The disruption of prepulse inhibition by social isolation in the Wistar rat: how robust is the effect? Pharmacol Biochem Behav (1998) 0.80
Rapid onset of true antidepressant action. Curr Psychiatry Rep (2007) 0.80
Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat. Behav Pharmacol (1998) 0.78
Effects of single and repeated restraint on the social behavior of male rats. Physiol Behav (1993) 0.77
Increased 5-HT2 receptor-mediated behavior 11 days after shock in learned helplessness rats. Eur J Pharmacol (1995) 0.75
Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat (2006) 2.89
Health-related searches on the Internet. JAMA (2004) 2.82
Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol (2011) 1.76
Serum interleukin-6 levels in colorectal cancer patients--a summary of published results. Int J Colorectal Dis (2009) 1.72
Does the internet harm health? Database of adverse events related to the internet has been set up. BMJ (2002) 1.55
Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nat Commun (2012) 1.48
P2 receptors and neuronal injury. Pflugers Arch (2006) 1.18
Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol (2003) 1.17
Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride. Cancer Chemother Pharmacol (2006) 1.13
sIL-6R: more than an agonist? Immunol Cell Biol (2007) 1.11
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients. Antimicrob Agents Chemother (2010) 1.08
Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J Clin Pharmacol (2005) 0.97
Expression pattern and functional relevance of epidermal growth factor receptor and cyclooxygenase-2: novel chemotherapeutic targets in pancreatic endocrine tumors? Am J Gastroenterol (2009) 0.97
Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia. J Antimicrob Chemother (2011) 0.93
Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides. Eur J Neurosci (2006) 0.92
Flavanones that selectively inhibit TRPM3 attenuate thermal nociception in vivo. Mol Pharmacol (2013) 0.92
Changes in purinergic signaling after cerebral injury -- involvement of glutamatergic mechanisms? Int J Dev Neurosci (2006) 0.92
Rodent cortical astroglia express in situ functional P2X7 receptors sensing pathologically high ATP concentrations. Cereb Cortex (2010) 0.92
Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries. Protein Eng Des Sel (2006) 0.89
High-performance liquid chromatographic assay for alpha-lipoic acid and five of its metabolites in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.89
Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity. Free Radic Biol Med (2005) 0.87
Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.87
Synthesis and characterization of some new phase II metabolites of the alkylator bendamustine and their identification in human bile, urine, and plasma from patients with cholangiocarcinoma. Drug Metab Dispos (2005) 0.86
Acute amygdaloid response to systemic inflammation. Brain Behav Immun (2011) 0.86
Endocrine disrupting chemicals affect the adipogenic differentiation of mesenchymal stem cells in distinct ontogenetic windows. Biochem Biophys Res Commun (2011) 0.85
Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes. Crit Care (2014) 0.85
Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production. Neuropsychopharmacology (2002) 0.85
Stress-induced cytokine changes in rats. Eur Cytokine Netw (2013) 0.84
Expression of purinergic receptors in the hypothalamus of the rat is modified by reduced food availability. Brain Res (2006) 0.84
In vivo assessment of antiemetic drugs and mechanism of lycorine-induced nausea and emesis. Arch Toxicol (2011) 0.82
Endogenous purinergic signaling is required for osmotic volume regulation of retinal glial cells. J Neurochem (2009) 0.82
Evidence for the combined participation of a C10 and a C15 precursor in the biosynthesis of moenocinol, the lipid part of the moenomycin antibiotics. Chembiochem (2003) 0.82
Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. Eur J Endocrinol (2007) 0.82
Amygdaloid signature of peripheral immune activation by bacterial lipopolysaccharide or staphylococcal enterotoxin B. J Neuroimmune Pharmacol (2012) 0.82
Identification and quantitation of the N-acetyl-L-cysteine S-conjugates of bendamustine and its sulfoxides in human bile after administration of bendamustine hydrochloride. Drug Metab Dispos (2008) 0.81
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults. Ther Drug Monit (2010) 0.81
The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo. PLoS One (2011) 0.81
Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine in beagle dogs. Toxicon (2010) 0.80
Mutations in the N-terminus of the major coat protein (pVIII, gp8) of filamentous bacteriophage affect infectivity. J Mol Microbiol Biotechnol (2003) 0.80
Electrical activity in rat cortico-limbic structures after single or repeated administration of lipopolysaccharide or staphylococcal enterotoxin B. Proc Biol Sci (2010) 0.79
P2Y1 receptors inhibit long-term depression in the prefrontal cortex. Neuropharmacology (2010) 0.79
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor. Breast Care (Basel) (2010) 0.78
A pilot study of bendamustine in advanced bile duct cancer. Anticancer Drugs (2007) 0.78
Nicotine induces DNA damage in human salivary glands. Toxicol Lett (2008) 0.78
Reduced food intake and body weight in mice deficient for the G protein-coupled receptor GPR82. PLoS One (2011) 0.77
Blockade of glutamate transporters leads to potentiation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex via group II metabotropic glutamate receptor activation. Neuropharmacology (2008) 0.76
Influence of protein binding on acrolein turnover in vitro by oxazaphosphorines and liver microsomes. J Clin Lab Anal (2005) 0.76
Neurobehavioural activation during peripheral immunosuppression. Int J Neuropsychopharmacol (2012) 0.76
Cyclic electrodeposition of PtCu alloy: facile fabrication of highly porous platinum electrodes. Adv Mater (2012) 0.75
Deletion of the cell adhesion adaptor protein vinculin disturbs the localization of GFAP in Bergmann glial cells. Glia (2013) 0.75
Comparative and integrative environmental assessment of advanced wastewater treatment processes based on an average removal of pharmaceuticals. Water Sci Technol (2013) 0.75
Evaluation of REMEDi HS in the diagnosis of dimethoate poisoning. Ther Drug Monit (2002) 0.75
[Purinergic modulation of the brain dopaminergic transmission: behavioral-pharmacologic conclusions]. Neuropsychopharmacol Hung (2008) 0.75
Development of a competitive reverse-transcription polymerase chain reaction for quantitative measurement of sulfotransferase subfamily 1A enzyme in human hepatoma cells. Anal Biochem (2003) 0.75
CYP2C9 polymorphisms in human tumors. Anticancer Res (2006) 0.75